标题
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments
作者
关键词
-
出版物
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-09-17
DOI
10.1007/s40257-023-00818-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Increased sensitivity to touch‐evoked itch (punctate hyperknesis) in prurigo nodularis and type 2 inflammation: a cross‐sectional pilot study
- (2023) Takashi Hashimoto et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Cost-effectiveness and Quality of Specialized and Routine Care in a German Cohort of Patients with Chronic Pruritus
- (2023) Svenja Müller et al. ACTA DERMATO-VENEREOLOGICA
- Serum Interleukin-13 and Caspase 8 are Elevated in Prurigo Nodularis
- (2023) Teresa Ju et al. ACTA DERMATO-VENEREOLOGICA
- 436 Nemolizumab monotherapy was associated with significant improvements in prurigo activity score in adult patients with moderate-to-severe prurigo nodularis: results from a phase 3 trial (OLYMPIA 2)
- (2023) Sonja Ständer et al. BRITISH JOURNAL OF DERMATOLOGY
- Prurigo nodularis is highly linked with neural sensitization disorders of pain among hospitalized adults in the United States – National Inpatient Sample 2016–2019
- (2023) Siri Choragudi et al. BRITISH JOURNAL OF DERMATOLOGY
- Failure of Dupilimab With Severe Prurigo Nodularis That Responded Well to Abrocitinib
- (2023) Ashley Vander Does et al. Dermatitis
- Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitis
- (2023) Natalia Alkon et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The effectiveness and safety of dupilumab in the management of refractory prurigo nodularis in 45 Chinese patients: A real‐life observational study
- (2023) Hao‐Yue Fang et al. JOURNAL OF DERMATOLOGY
- Transcriptomic landscape of prurigo nodularis lesional skin CD3+ T cells using single-cell RNA-Sequencing
- (2023) Andreea Calugareanu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A polygenic risk score for predicting racial and genetic susceptibility to prurigo nodularis
- (2023) Chirag Vasavda et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tralokinumab shows clinical improvement in patients with prurigo nodularis-like phenotype atopic dermatitis: A multicenter, prospective, open-label case series study
- (2023) Elena Pezzolo et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The blood proteomic signature of prurigo nodularis reveals distinct inflammatory and neuropathic endotypes: A cluster analysis
- (2023) Varsha Parthasarathy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials
- (2023) Gil Yosipovitch et al. NATURE MEDICINE
- Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study
- (2023) Howard Sofen et al. EClinicalMedicine
- Myeloid dendritic cells are increased in the lesional skin and associated with pruritus in patients with prurigo nodularis
- (2023) Taoming Liu et al. MedComm
- Chronic prurigo
- (2022) Laurent Misery BRITISH JOURNAL OF DERMATOLOGY
- Cutaneous Transcriptomics Identifies Fibroproliferative and Neurovascular Gene Dysregulation in Prurigo Nodularis Compared with Psoriasis and Atopic Dermatitis
- (2022) Nishadh Sutaria et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
- (2022) Vivian Y. Shi et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nemolizumab: First Approval
- (2022) Susan J. Keam DRUGS
- Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances
- (2022) S. Ständer et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- RNA sequencing reveals the transcriptome profile of the atopic prurigo nodularis with severe itching
- (2022) Yixin Shao et al. EXPERIMENTAL DERMATOLOGY
- Transcriptomic, Epigenomic, and Neuroanatomic Signatures Differ in Chronic Prurigo, Atopic Dermatitis, and Brachioradial Pruritus
- (2022) Konstantin Agelopoulos et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo
- (2022) David Rosmarin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria
- (2022) Dorothea Terhorst‐Molawi et al. ALLERGY
- Successful treatment of prurigo nodularis with tofacitinib: The experience from a single center
- (2022) Taoming Liu et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis
- (2022) Varsha Parthasarathy et al. Frontiers in Medicine
- Extracellular matrix and dermal nerve growth factor dysregulation in prurigo nodularis compared to atopic dermatitis
- (2022) Junwen Deng et al. Frontiers in Medicine
- Itch intensity in prurigo nodularis is closely related with dermal interleukin‐31, oncostatin M, IL‐31 receptor alpha, and oncostatin M receptor beta
- (2021) Takashi Hashimoto et al. EXPERIMENTAL DERMATOLOGY
- Pruritus Intensity Scales across Europe: A Prospective Validation Study
- (2021) M. Storck et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Interleukin‐31: The ‘itchy’ cytokine in inflammation and therapy
- (2021) Angeliki Datsi et al. ALLERGY
- Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies
- (2021) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Prevalence, incidence and presence of comorbidities in patients with prurigo and pruritus in Germany: A population‐based claims data analysis
- (2021) M. Augustin et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Chronic Prurigo: Similar Clinical Profile and Burden Across Clinical Phenotypes
- (2021) Claudia Zeidler et al. Frontiers in Medicine
- Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab
- (2021) Lam C. Tsoi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans
- (2021) Nishadh Sutaria et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open‐label extension phase
- (2021) E. Weisshaar et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- One third of Chronic Prurigo patients scratch automatically and in the absence of itch – a naturalistic study of 1142 patients
- (2021) G. Schneider et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors
- (2021) Chisa Nakashima et al. ALLERGOLOGY INTERNATIONAL
- Chronic Nodular Prurigo: Clinical Profile and Burden. A European Cross‐sectional Study
- (2020) M.P. Pereira et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis
- (2020) Sonja Ständer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prurigo Nodularis: Pathogenesis and Management
- (2020) Kyle A. Williams et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2020) Eric L Simpson et al. LANCET
- The burden in chronic prurigo: patients with chronic prurigo suffer more than patients with chronic pruritus on non‐lesional skin
- (2020) C. Zeidler et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response
- (2020) Husein Husein-ElAhmed et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Dupilumab for pediatric prurigo nodularis: A case report
- (2020) Tahel Fachler et al. PEDIATRIC DERMATOLOGY
- Pathophysiology, diagnosis, and pharmacological treatment of prurigo nodularis
- (2020) Kyle A. Williams et al. Expert Review of Clinical Pharmacology
- Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial
- (2019) Sonja Ständer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- How to define chronic pruritus – symptom or disease?
- (2019) Sonja Ständer EXPERIMENTAL DERMATOLOGY
- Peripheral sensitisation and loss of descending inhibition is a hallmark of chronic pruritus
- (2019) Esther M. Pogatzki-Zahn et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Diagnostic and Treatment Algorithm for Chronic Nodular Prurigo
- (2019) Hartmut F. Ständer et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Real-world prevalence of prurigo nodularis and burden of associated diseases
- (2019) Amy H. Huang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Ethnic differences and comorbidities of 909 Prurigo Nodularis patients
- (2018) Emily Boozalis et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo
- (2018) J. Pölking et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The self-assessed psychological comorbidities of prurigo in European patients: a multicentre study in 13 countries
- (2018) E. Brenaut et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Position Statement: Linear prurigo is a subtype of chronic prurigo
- (2018) M.P. Pereira et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- There is no functional small-fibre neuropathy in prurigo nodularis despite neuroanatomical alterations
- (2017) Manuel P. Pereira et al. EXPERIMENTAL DERMATOLOGY
- JAK inhibitors in dermatology: The promise of a new drug class
- (2017) William Damsky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo
- (2017) M.P. Pereira et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Stigma – Risikofaktor und Konsequenz suizidalen Verhaltens
- (2017) N. Oexle et al. NERVENARZT
- Intraepidermal Nerve Fibre Density is Decreased in Lesional and Inter-lesional Prurigo Nodularis and Reconstitutes on Healing of Lesions
- (2016) S Bobko et al. ACTA DERMATO-VENEREOLOGICA
- Anxiety, depression and suicide in patients with prurigo nodularis
- (2016) K.M. Jørgensen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Relations between the characteristics and psychological comorbidities of chronic pruritus differ between men and women: women are more anxious than men
- (2015) A. Stumpf et al. BRITISH JOURNAL OF DERMATOLOGY
- The pathogenesis of Prurigo nodularis - ‘Super-Itch’ in exploration
- (2015) C. Zeidler et al. EUROPEAN JOURNAL OF PAIN
- Nihil certum: Historische Entwicklung des Begriffs Prurigo
- (2014) C.M. Schürmann et al. HAUTARZT
- Evaluation of the Antipruritic Effects of Topical Pimecrolimus in Non-Atopic Prurigo Nodularis: Results of a Randomized, Hydrocortisone-Controlled, Double-Blind Phase II Trial
- (2013) Dorothee Siepmann et al. DERMATOLOGY
- Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy
- (2011) B. Schuhknecht et al. BRITISH JOURNAL OF DERMATOLOGY
- A pilot quality-of-life instrument for pruritus
- (2008) Nisha S. Desai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation